Front. Physiol. Frontiers in Physiology Front. Physiol. 1664-042X Frontiers Media S.A. 10.3389/fphys.2019.01116 Physiology Mini Review Population History and Altitude-Related Adaptation in the Sherpa Bhandari Sushil * Cavalleri Gianpiero L. * Department of Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland

Edited by: Tatum S. Simonson, University of California, San Diego, United States

Reviewed by: Cynthia M. Beall, Case Western Reserve University, United States; Edward Gilbert-Kawai, University College London, United Kingdom; Lorna Grindlay Moore, University of Colorado Denver, United States

 *Correspondence: Sushil Bhandari, sushilbhandari@rcsi.ie Gianpiero L. Cavalleri, gcavalleri@rcsi.ie

This article was submitted to Environmental, Aviation and Space Physiology, a section of the journal Frontiers in Physiology

 28 08 2019 2019 10 1116 30 01 2019 12 08 2019 Copyright © 2019 Bhandari and Cavalleri. 2019 Bhandari and Cavalleri

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

The first ascent of Mount Everest by Tenzing Norgay and Sir Edmund Hillary in 1953 brought global attention to the Sherpa people and human performance at altitude. The Sherpa inhabit the Khumbu Valley of Nepal, and are descendants of a population that has resided continuously on the Tibetan plateau for the past ∼25,000 to 40,000 years. The long exposure of the Sherpa to an inhospitable environment has driven genetic selection and produced distinct adaptive phenotypes. This review summarizes the population history of the Sherpa and their physiological and genetic adaptation to hypoxia. Genomic studies have identified robust signals of positive selection across EPAS1, EGLN1, and PPARA, that are associated with hemoglobin levels, which likely protect the Sherpa from altitude sickness. However, the biological underpinnings of other adaptive phenotypes such as birth weight and the increased reproductive success of Sherpa women are unknown. Further studies are required to identify additional signatures of selection and refine existing Sherpa-specific adaptive phenotypes to understand how genetic factors have underpinned adaptation in this population. By correlating known and emerging signals of genetic selection with adaptive phenotypes, we can further reveal hypoxia-related biological mechanisms of adaptation. Ultimately this work could provide valuable information regarding treatments of hypoxia-related illnesses including stroke, heart failure, lung disease and cancer.

 Sherpa Tibetan Sherpa physiology hypoxia adaptation genetic selection high altitude adaptation natural selection Irish Research Council10.13039/501100002081 Science Foundation Ireland10.13039/501100001602 Introduction

The term “sher-pa” is the Tibetan for “eastern-people”. The Sherpa reside primarily in the Solukhumbu district of Nepal but there are also smaller settlements in the Tibet Autonomous Region of China. The Sherpa speak a Tibetan dialect, and they share similar cultural and religious practices with Tibetans. They are traditionally engaged in farming; cultivating barley, potatoes and rearing yak and sheep. Starting with the first Everest expeditions in the 1920’s, the Sherpa have become renowned for their ability as mountaineers and today they often aid and lead climbing expeditions in the Himalayas. Examples of their exceptional climbing feats include the first ascent of Mount Everest by Tenzing Norgay Sherpa, who accompanied Sir Edmund Hillary in the final stage of the 1953 expedition and Ang Rita Sherpa (known as “The Snow Leopard”) who, between 1983 and 1996, summited Everest ten times without the use of supplemental oxygen. The remarkable tolerance of the Sherpa to hypoxia has, over the last 60 years, been a focus of attention for the scientific community, in particular physiologists (Gilbert-Kawai et al., 2014).

The Sherpa are direct descendants of an ancestral population that has resided continuously on the Tibetan plateau for the past 25,000 to 40,000 years (Aldenderfer, 2011; Zhang et al., 2018). This long exposure to the evolutionary pressure presented by high altitude has driven physiological adaptation, which in turn has allowed the Sherpa to thrive. The adaptive physiological makeup of the Sherpa can inform on treatments for hypoxia-related illness including pulmonary, cardiac, neurological and renal disorders (Martin et al., 2013; Luks and Hackett, 2014; Gilbert-Kawai et al., 2015). Thus, studying the Sherpa at altitude offers a unique, “natural laboratory” that can provide insight to the molecular mechanisms of hypoxia.

An early paper on Sherpa physiology, published in 1965, suggested that the Sherpa have an efficient mechanism of oxygen utilization at the cellular level, allowing them to perform well under hypoxia (Lahiri and Milledge, 1965). Since then, our knowledge of Sherpa adaptation has grown, largely by comparing different physiological parameters between the Sherpa and people of lowland origin. With the development of high throughput DNA genotyping and sequencing platforms, genomic studies of indigenous high-altitude populations, including the Sherpa, have begun to emerge. These have provided insight into population history and genetic signatures of altitude-driven natural selection. In this review, we (1) summarize the population history of, (2) describe distinct adaptive phenotypes and (3) discuss signatures of selection, in the Sherpa. We highlight the need for further research connecting genetic factors to physiological adaptation in the Sherpa at extreme altitude.

 The Sherpa, a Recently Derived Tibetan Population

Stone tools used by early humans have been found at Nwya Devu in central Tibet at an altitude of 4,600 m. Dating to 30,000 to 40,000 years before present (YBP), these findings represent the earliest archeological record of human colonization of the Tibetan plateau (Zhang et al., 2018). Genetic studies have suggested that the ancestors of both the Sherpa and Tibetans diverged from a Han Chinese population and arrived on the Tibetan plateau from lowland East Asia around 40,000 years ago (Qi et al., 2013; Jeong et al., 2014).

The prevailing hypothesis is that, during the 16th century, the ancestors of the Sherpa migrated from Tibet to the Khumbu Valley of Nepal, driven by political and religious turmoil resulting from a Mongol invasion (Oppitz, 1974). The presence of Sherpa-specific mitochondrial DNA (mtDNA) lineages (Kang et al., 2013) in a Nepalese context, with an estimated age of less than 1,500 years and derived from Tibetans, further supports this hypothesis of a recent migration of the Sherpa to the Khumbu valley (Bhandari et al., 2015).

There is a long history of migration from the Tibetan plateau to Nepal. To illustrate, genomic analysis of human dental samples (dating to between 1,700 and 3,000 YBP) from a northern region of Nepal show strong affinity for contemporary Tibetans (Jeong et al., 2016). Analysis of both autosomal data (Lu et al., 2016; Gnecchi-Ruscone et al., 2017) and uniparental mtDNA and Y-chromosome markers (Bhandari et al., 2015) have shown the Sherpa and Tibetans to share relatively recent common ancestry. Tibetans also share recent common ancestry with other Nepalese populations including the Rai, Magar, Tamang, and Gurung (Cole et al., 2017). The Sherpa share more genetic affinity with these Tibeto-Burman speaking populations than with other Indo-Aryan populations of Nepal. However, the Sherpa are distinct from other Nepalese populations in that the Sherpa have elevated levels of runs of homozygosity (Cole et al., 2017), and illustrate very little or no admixture with Nepalese or South Asian populations (Cole et al., 2017). Thus, the Khumbu Valley Sherpa can be considered from the perspective of population genetics as a “bottlenecked” population recently derived from Tibetans.

 Comparative Physiological Studies Between Sherpa and Lowlanders

In 1952, Griffith Pugh conducted a series of pioneering physiological experiments on Mount Cho Oyo (at 8,188 m, 20 km west of Mount Everest) that suggested a superior work capacity of the Sherpa at high altitude (Pugh, 1962; Pugh et al., 1964). They also provided the scientific rationale for the hydration, nutrition and oxygen requirements for the first Everest summiting in 1953 (Milledge, 2002). Although the physiology of the Sherpa has been studied over the intervening 60 years, the scientific literature is limited in number, and most of the studies are based on small sample sizes. There are obvious challenges to studying the Sherpa; they reside in a remote region, at an altitude over 2,800 m, where altitude sickness is common for sojourners. Despite this, several remarkable findings have emerged and below we discuss specific phenotypes that may be linked to hypoxia-related genetic signals of selection reported to date. For a discussion of other hypoxia-related physiological parameters studied in Sherpa, such as ventilation, lung volume, exercise capacity and cerebral function (see Gilbert-Kawai et al., 2014; Table 1).

Physiological parameters studied in Sherpa and lowlanders at altitude.

Parameter(s) Sherpa at high altitude
 Lowlander at altitude (meter)
 Reference(s)
Sample size Parameter value Altitude Sample size Duration (days) Parameter value
Heart rate while working at 900 kg⋅m/min-beats/min 1 162 5,800 2 240 122 Pugh, 1962; Pugh et al., 1964
Lung diffusion capacity for oxygen-ml/min 1 97 5,800 2 240 52.5 Pugh, 1962
Basal metabolic rate, kcal/m2 h 3 46.1 ± 1.0 5,800 8 240 41.1 ± 3.6 Gill and Pugh, 1964
10 different physiological parameters; measured, to test oxygen utilization at the cellular level 4 efficiently used O2 4,880 3 60 less efficient to use O2 Lahiri and Milledge, 1965
Heart rate (while work rate at 1,265 kg-m/min)- beats/min 4 198 4,880 2 63 146 Lahiri et al., 1967
Partial pressure of carbon dioxide in the arterial blood, mm Hg 4 28.6 4,880 5 60 25.9 Lahiri and Milledge, 1967
Hemoglobin level in Tibetans living at 3658 m in Nepal; g/l00 ml 52 Male; 16.8 ± 1.4; Female: 14.5 ± 0.7 – Adams and Shresta, 1974
Hemoglobin level in Tibetans living at 4000 m in Nepal; g/l00 ml 51 Male; 17.0 ± 1.25; Female:15.3 ± 0.8 – Adams and Strang, 1975
Ratio of 2, 3 diphosphoglycerate and hemoglobin 7 0.9 3,900 2 30 1.26 Morpurgo et al., 1976
Mean oxygen half saturation of hemoglobin 7 27.3 ± 1.8 3,500 7 120 28.2 ± 1.3 Samaja et al., 1979
Arterial oxygen saturation (SaO2) 10 88 ± 0.74 4,243 25 12 85.6 ± 1.0 Hackett et al., 1980
Body weight changes- Mean weight loss (kg) 4 constant 5,400 13 25 1.9 to 4 Boyer and Blume, 1984
Hypoxic ventilatory response (HVR)-end-tidal PO2, 40 Torr 6,300 9 25 21.2 ± 5.4 Schoene et al., 1984
Partial pressure of oxygen in arterial blood (Torr) 6 34.5 ± 3.2 5,400 9 – 41.0 ± 3.3 Santolaya et al., 1989
Partial pressure of carbondioxide in arterial blood (Torr) 6 27.5 ± 2.2 5,400 9 – 20.0 ± 2.8 Sutton et al., 1988
Hemoglobin oxygen affinity values 14 29.8 ± 1.9 – 1 – 19 Winslow et al., 1989
Resting glucose appearance rate at sea level (1.79 ± 0.02) mg.kg−l.min-1 – – 4,300 7 21 3.59 ± 0.08 Brooks et al., 1991
HVR shape parameter A, (mean ± SE) 27 121 ± 17 3,658 30 9 ± 1 year 81 ± 10 Zhuang et al., 1993
Resting mean pulmonary arterial pressure SE mmHg 5 15 ± 1 22 28 ± 2 Groves et al., 1993
Glucose metabolic rates of myocardial regions 6 0.32 ± 0.05 226 6 0.20 ±0 04 Holden et al., 1995
Brain glucose metabolic rates 6 0.71 6 19 0.73 Hochachka et al., 1996b
Signs of mild cortical atrophy 7 Seen in 1 21 Seen in 13 Garrido et al., 1996
Partial pressure of carbon dioxide, mm Hg 5 28.8 ± 1.2 3,400 4 40 22.0 ± 0.4 Samaja et al., 1997
Mean arterial blood pressure, mm Hg 9 83 ± 6 4,243 10 7 94 ± 7 Jansen et al., 2000
Forced expiratory volume of adult male (%) 146 110(107−114) 3,840 103 103.8 (100.4-107.3) Havryk et al., 2002
Heart Rate (beats min–1) means ± S.D. 7 167 ± 10 5,050 10 28 149 ± 7 Marconi et al., 2004
Carried loads of their body weight (mean ± SD) 96 93 ± 36% 2,880 10 75% Bastien et al., 2005a, b, 2016
Arterial oxygen saturation (SaO2) or (SpO2) – – 5,620 lower SaO2 in Han than Tibetans Wu, 1990; Wu and Kayser, 2006
Arterial oxygen saturation, % 10 88 ± 3 40 10 97 ± 2 Jansen et al., 2007
Statistically significant gender specific differences in SpO2 Adult Tibetan female show higher SpO2 value than male Weitz and Garruto, 2007
Serum angiotension-converling enzyme activity, IU/L/37°C 105 14.5 ± 0.4 1,300 111 14.7 ± 0.4 Droma et al., 2008
Mean arterial oxygen content at 8,400 m (26% lower than at 7100 m) – – 8,400 4 – 145.8 ml per L Grocott et al., 2009
Muscle phosphocreatine recovery halftime- PCrtl/2 (s) 7 22.2 ± 1.6 50 7 – 16.1 ± 1.1 Edwards et al., 2010
Radial arterial plasma NO2–(nmol I–1) – – 4,559 26 4 263.6 ± 61.2 Bailey et al., 2010
Middle cerebral artery diameter [at 6,400 m = 6.66 mm] – – 7,950 5 71 9.34 mm Wilson et al., 2011
Flow-mediated dilatation (FMD)-shear rate 12 24490 ± 7230 5,050 12 14 14802 ± 5306 Lewis et al., 2014
Arterial oxygen saturation (mean ± SE) 13 86 ± 1 5,050 13 9 83 ± 2 Faoro et al., 2014
Hemoglobin level ml. min(−l). mmHg(−l) 13 61 ± 4 5,050 13 9 37 ± 2 Faoro et al., 2014
Lung diffusing capacities 13 226 ± 18 5,050 13 9 153 ± 9 Faoro et al., 2014
Systolic pulmonary artery pressure 95 29.4 ± 5.5 13 64 – 23.6 ± 4.8 Bruno et al., 2014
Left ventricular untwisting velocity, °/s 11 −93 ± 31 5,050 9 13 −153 ± 38 Stembridge et al., 2014
Right ventricular isovolumic ralaxation time, ms 11 64 ± 20 5,050 9 13 78 ± 14 Stembridge et al., 2015
No significant differences of dietary nitrate supplementation on AMS score – – 4,559 28 7 p = 0.29, p = 0.47 Cumpstey et al., 2017
Arterial oxygen saturation (%, 95% CI of Mean) – – 5,300 11 13 73.0 (70.3–75.5) Luks et al., 2017
Relative PPARA mRNA expression of muscles tissues 15 0.5158 5,300 10 19 1.0045 Horscroft et al., 2017
Post reproductive, Tibetan women (n=959)-Hemoglobin concentration, gm/dl – 13.8 – – Cho et al., 2017
Increase in nocturnal time course of blood oxygen saturation level at rest – – 3,050 10 21 94.5% (91-97) Tannheimer et al., 2017
FMD unchanged (in rest and maximal exercise), at low and high altitude – – 3,800 9 7 (6.3 ± 1.3)% Tymko et al., 2017a
Brachial artery blood flow [at Sea level- (142.7 ± 30.6)], ml/min – – 5,050 14 21 53.1 ± 11.1 Tymko et al., 2017b
Number of circulating microparticles in blood (CD 66b+)/μ1 (21 ± 4) Sea level – 3,800 10 3 74 ± 17 Tremblay et al., 2017
Birth-weight (kg) in Tibetans & Han; at 3,000–4,000 m altitude 100 3.14 (3.06, 3.22) <4,000 100 2.61 (2.34, 2.88) Moore et al., 2001
Case report of a 32 week gestation Sherpa at 5160 m and her data after 10 month postpartum No apparent maternal, fetal or neonatal complications – Davenport et al., 2018
Arterial oxygen pressure (PaO2; mm Hg) – – 4,100 8 50 54 ±1.2 Lundby et al., 2018
Prefatigue, maximal voluntary contraction torque, N. m 9 50.1 ± 11.3 5,050 9 – – Ruggiero and Mcneil, 2018
Maximal voluntary contractile force (kg) 10 44.3 ± 14.1 5,050 12 10 58.2 ± 8.1 Ruggiero et al., 2018
Brachial artery flow-mediated dilation (FMD) 12 5.8 ± 2.8% 5,050 22 10 3.8 ± 2.8% Tremblay et al., 2018
Resting posterior cerebral artery velocity – – 4.240 10 13 43 cm/s Leacy et al., 2018
Lowland origin; Female SpO2; Mean (SD), (%)[95.2 (1.2); at 600 m] – – 3,500 20 1 76.7 (5.6) Burtscher et al., 2018
Partial pressure of arterial carbon dioxide. mmHg 11 32.1 ±2.5 5,050 21 21 30.0 ±1.9 Willie et al., 2018
Peripheral oxygen saturation in female [at 600 m; 96.9 (1.0)] Mean (SD) % – – 3,840 20 1 86.5 (6.5) Burtscher et al., 2019
SpO2 (%) [at Sea Level (244 m) is 98 ± 1] – – 3.800 12 10 89.1 ± 3 Stembridge et al., 2019
Free cysteine and plasma total free thiol concentrations – – 4,559 4 Elevated at 4,559 m than at 50 m Cumpstey et al., 2019
Sublingual capillary total vessel density [at Sea Level; 18.81 ± 3.92 mm mm–2 – – 7,042 10 21 21.25 ±2.27 Hilty et al., 2019
Sympathetic nerve activity, burst frequency (bursts min–1) 8 22 ± 11 5,050 14 20 30 ± 9 Simpson et al., 2019
Hemoglobin Concentration

The hypoxic challenge presented by high altitude drives changes in hemoglobin concentration. Elevated hemoglobin levels (≥19 g/dl in females; and ≥21 g/dl in males) resulting from hypoxia can lead to chronic mountain sickness (Leon-Velarde et al., 2005). Relative to lowland controls, the literature suggests the Sherpa display lower hemoglobin concentrations at high altitude (Beall and Reichsman, 1984; Wu et al., 2013; Bhandari et al., 2016). Sherpa women with lower hemoglobin concentrations (13.8 g/dl ± 1.3 g/dl) are reported to have better reproductive outcomes (Beall et al., 1997, 2004; Cho et al., 2017). Increased exercise capacity has been reported in Tibetan males with a low erythropoietic response (Simonson et al., 2015). It is yet to be determined whether the lower hemoglobin concentration observed in Sherpa is due to a blunted erythropoietic response or to some other physiological parameters that impact hemoglobin concentration.

 Nitric Oxide Concentration

Nitric oxide acts as a vasodilator and is believed to protect against pulmonary hypertension at high altitude (Busch et al., 2001). It also plays a role in haematocrit regulation by controlling blood viscosity (Ashmore et al., 2014). Serum nitric oxide levels have been reported as reduced in the Sherpa relative to lowlanders (Droma et al., 2006), and a recent study reported no differences in circulating nitric oxide metabolites [N-nitrosamine (RNNO), S-nitrosothiol, nitrate, or nitrite concentrations] between Sherpa and lowlanders at both low and high altitude (Horscroft et al., 2017). However, a non-synonymous variant (rs549340789) in NOS1 (nitric oxide synthases 1) has been identified as under positive selection in the Sherpa (Zhang et al., 2017). Thus, it seems that nitric oxide may play an important role in hypoxic adaptation (Erzurum et al., 2007; Beall et al., 2012), but the exact mechanisms remain poorly understood.

 Microcirculation

Lowlanders exhibit, in a hypoxic environment, reduced sublingual microcirculatory blood flow (Martin et al., 2009). However, the Sherpa maintain sublingual capillary densities and microcirculatory blood flow (Gilbert-Kawai et al., 2017) at altitude. Compared to mountaineers of European-ancestry, during an expedition to Mount Everest, Sherpa exhibit elevated basal levels of angiogenic elements including vascular endothelial growth factor A (VEGF-A), interleukins (IL-8) and lymphangiogenic factors (VEGF-C and D), which likely facilitate increased microcirculatory flow (Patitucci and Lugrin, 2009). The Sherpa display an elevated oxygen unloading rate, and increased myogenic activity relative to lowlanders, further supporting higher peripheral microcirculatory perfusion (Davies et al., 2018). Following a defined period of induced leg occlusion and muscle ischemia, the Sherpa are reported to display increased blood flow velocity, relative to lowlanders (Schneider et al., 2001). This is likely due to differences in conduit vessel function. Thus, the Sherpa appear to exhibit distinct microcirculation patterns, which might facilitate increased tissue oxygen transfer to overcome hypoxia.

 Pulmonary and Cardiac Physiology

The Sherpa have greater spirometry values, forced expiratory volumes and forced vital capacity relative to lowlanders at high altitude (Pugh, 1962; Havryk et al., 2002). Lowlanders often experience apnea-induced brady-arrhythmias at high altitude, while Sherpa typically do not (Busch et al., 2017). The Sherpa display lower pulmonary vascular resistance and smaller left ventricular end-diastolic volume (Stembridge et al., 2014). However, the mechanism by which this reduced myocardial relaxation impacts on the exercise capacity of the Sherpa is unclear (Stembridge et al., 2015).

Evidence suggests a shift in cardiac substrate preference, from fat to glucose, in Sherpa relative to lowland controls (Holden et al., 1995). Some patients with heart failure display a reduction of the myocardial PCr to ATP ratio (Neubauer et al., 1997). Lowlanders returning from high altitude also display a significant decrease in myocardial PCr/ATP ratio (Holloway et al., 2011), but this ratio remains steady in the Sherpa (Hochachka et al., 1996a).

 Skeletal Muscle

Sherpa muscle contains a significantly greater number of capillaries per cross-sectional area, in comparison to lowlanders (Kayser et al., 1991). Sherpa also display a reduced mitochondrial content, but their muscle is somehow maximizing the oxygen consumption to mitochondrial volume ratio (Kayser et al., 1991; Horscroft et al., 2017). Under hypoxia, Sherpa skeletal muscle prefers carbohydrate over fatty acids as a metabolic substrate (Murray, 2009). Sherpa muscle maintains fatty acid oxidation relative to lowlanders at high altitude. Incomplete fatty acid oxidation results in production of byproducts such as acylcarnitines and reactive oxygen species. Acylcarnitines and markers of oxidative stress (e.g., reduced/oxidized glutathione and methionine sulfoxide) are increased in lowlander muscle relative to the Sherpa (Gelfi et al., 2004; Horscroft et al., 2017). However, oxidative damage in lowlanders was reduced to levels comparable with the Sherpa, where acclimatization has taken place (Janocha et al., 2017). Lactate dehydrogenase activity is elevated in Sherpa muscle (Allen et al., 1997; Horscroft et al., 2017), indicating greater capacity for anaerobic lactate production. With increasing altitude, lowlanders experience a gradual reduction in phosphocreatine (PCr) and ATP levels (Levett et al., 2015). But the Sherpa maintain PCr and ATP levels at altitude (Horscroft et al., 2017). Thus, the superior muscle energetics displayed by the Sherpa is probably the result of adaptation at the metabolic level.

 Birth Weight

Women of European and Han Chinese ancestry exhibit reduced birth weights following gestation at high altitude, quantified at 100 g reduction for every 1,000 m elevation (Moore, 2003; Julian et al., 2009; Moore et al., 2011). The Sherpa (and Tibetans), however, maintain normal birth weight at both low (1,330 m) and high (3,930 m) altitude (Smith, 1997; Moore et al., 2001). Genes including PPARA are expressed in the placenta (Barak et al., 2008) and have been shown to influence female reproductive function (Bogacka et al., 2015). HIFs play a critical role in mammalian embryo and placental development (Dunwoodie, 2009; Pringle et al., 2009). EPAS1 expression appears reduced in umbilical endothelial cells and placentas of Tibetan women (Peng et al., 2017). Intronic variants in CCDC141 have been shown in Tibetan and Sherpa women to associate with the number of live births, and the same locus also shows evidence of positive selection (Jeong et al., 2018). The increased reproductive success of the Sherpa is therefore likely to be, at least in part, due to cardiac-related traits (Jeong et al., 2018) and placental adaptation (Burton et al., 2016). Further studies are required to understand the molecular mechanisms by which the Sherpa maintain normal intrauterine growth at altitude.

In summary, the Sherpa display distinct physiological responses to hypoxia that contrast to lowlanders at high altitude (Table 1). These are presumably the result of exposure over many generations to the hypoxia-related selective pressure presented by the Tibetan plateau. Indeed, some examples have already emerged of specific genetic signatures of selection associating with distinct adapative traits (Simonson, 2015; Moore, 2017).

 Signatures of Altitude-Related Genetic Selection in the Sherpa

With developments in sequencing and genotyping technology over the past decade, it has become possible to identify population-specific signatures of selection for adaptation across the human genome. There are now several complementary genomic tests available for detecting genetic selection (Scheinfeldt and Tishkoff, 2013) and the application of these tests to data from indigenous high-altitude people including the Sherpa have identified numerous and remarkable genetic signals of selection. Here, we focus on the three most robust signals of selection detected to date in the Sherpa: EPAS1, EGLN1, and PPARA (Table 2).

A summary of genetic adaptations reported in the Sherpa, and replication in other population(s) or species.

Genes name(s) Sherpa
 Other population(s) or species Reference(s)
Sample Size Reference(s)
ACE 105 Droma et al., 2008 Elite European descent athletes Montgomery et al., 1998; Jones et al., 2002
HIF-la 20 Suzuki et al., 2003 – –
eNOS 105 Droma et al., 2006
EPAS1 105 Hanaoka et al., 2012 Tibetan Beall et al., 2010; Simonson et al., 2010; Yi et al., 2010; Bigham et al., 2010; Peng et al., 2011; Wang et al., 2011; Xu et al., 2011
51 Jeong et al., 2014 Deedu Mongolian Xing et al., 2013
582 Bhandari et al., 2016 Denisovan Huerta-Sánchez et al., 2014
3.4 kb Copy Number Deletion-80 kb downstream of EPAS1 582 Bhandari et al., 2016 Tibetan Lou et al., 2015
EGLN1 51 Jeong et al., 2014 Tibetan Lorenzo, 2010; Simonson et al., 2010; Yi et al., 2010; Xiang et al., 2013; Lorenzo et al., 2014
582 Bhandari et al., 2016 Andean Bigham et al., 2009; Bigham et al., 2010
111 Zhang et al., 2017 Daghestani Pagani et al., 2012
PPARA 15 Horscroft et al., 2017 Tibetan Simonson et al., 2010; Peng et al., 2011
Kinota et al., 2018 (Amhara and Omotic) Ethiopian Scheinfeldt et al., 2012
HYOUI/HMBS 51 Jeong et al., 2014 – –
EPAS1, EGLN1, DLG1, MARCH8, CDCA7L, HEATR5B, EDAR, ZNF644, TTC24, TMEM247, OXR1, ALDH31 111 Zhang et al., 2017 – –
NOS1 111 Zhang et al., 2017 Tibetan (GCH1), Andeans (NOS2) Bigham et al., 2009; [opetwcitep]B20,B59[clotwcitep]Bigham et al., 2010; He et al., 2018
ANGPT1 111 Zhang et al., 2017 Tibetan and grey wolves of TAR, China Jeansson et al., 2011; Wang et al., 2011
EPAS1, EGLN1, RP11-384F7.2 AC068633.1, ZNF53 2, HLA-DOB1/HLA-DPB1 10 Arciero et al., 2018 – –
ANKH 10 Arciero et al., 2018 Pigs of TAR, China Ai et al., 2014
GRB2 10 Arciero et al., 2018 Tibetans Li et al., 2016
Polygeneic Adaptation {Gene subnetworks like the nested integrin associated pathways (i.e., Integrin β-1, Integral α6−β4 and Integrin involved in angiogenesis),CMYB and C-MYC transcription factor pathways} 31 Gnecchi-Ruscone et al., 2017, 2018 Tibetans Gnecchi-Ruscone et al., 2018
EPAS1, EGLN1.CCDC141,PAPOLA, VRK1, C6orf195, CTBP2, TEX36, EDRF1 103 Jeong et al., 2018 Tibetans Jeong et al., 2018
Endothelial PAS Domain-Containing Protein 1 (EPAS1)

One of the earliest signals for altitude-related adaptation to emerge from genomic selection studies was EPAS1. Initially discovered in Tibetans (Beall et al., 2010), the EPAS1 signal has been replicated in multiple other Tibetan populations (Bigham et al., 2010; Simonson et al., 2010; Yi et al., 2010; Peng et al., 2011; Wang et al., 2011; Xu et al., 2011) as well as the Sherpa (Hanaoka et al., 2012; Jeong et al., 2014; Bhandari et al., 2016). The selected EPAS1 haplotype is associated with lowered hemoglobin concentrations (Beall et al., 2010). Remarkably, it seems the adaptive EPAS1 haplotype likely descends from an introgression event with the Denisovan people, an extinct species of archaic humans (Huerta-Sánchez et al., 2014; Hu et al., 2017). A 3.4 kb copy number deletion, downstream of EPAS1, is elevated in frequency, in Tibetans and Sherpas relative to lowland controls (Lou et al., 2015). This deletion is in strong linkage disequilibrium with the previously reported (Beall et al., 2010) EPAS1 haplotype and has also been associated with lower hemoglobin levels. The actual functional EPAS1 variant(s) that are conferring advantage in relation to hypoxic adaptation remain unknown. However, the intronic and intergenic location of the selected variants would be consistent with a role in HIF-related transcriptional regulation.

EPAS1 encodes the HIF2 alpha subunit of HIF2. The postnatal deletion of EPAS1 in adult mice causes anaemia (Gruber et al., 2007). Some cases of erythrocytosis are caused by missense mutations (e.g., G536W) in EPAS1 (Percy et al., 2008). Mice carrying the EPAS1 G536W mutation display excessive erythrocytosis and pulmonary hypertension (Tan et al., 2013). Another study in heterozygous EPAS1 knockout mice reported a blunted physiological response to chronic hypoxia (Peng et al., 2017). Further in-vivo and in-vitro studies are necessary to understand how the adaptive version of the EPAS1 gene is shaping human adaptation to altitude.

 Egl-9 Family Hypoxia Inducible Factor 1 (EGLN1)

Another high altitude genetic selection signal to emerge from early studies on Tibetans was EGLN1 (Simonson et al., 2010; Yi et al., 2010). Similar to EPAS1, this signal was later demonstrated in the Sherpa (Jeong et al., 2014). Two functional EGLN1 mutations (rs12097901, D4E, and rs186996510, S127C) appear to be driving the selection signal and are present in both Sherpa (Bhandari et al., 2016) and Tibetans (Lorenzo, 2010; Xiang et al., 2013; Lorenzo et al., 2014). Whether the mode of action of these two mutations is via gain of function (Lorenzo et al., 2014) or loss of function (Song et al., 2014) remains unclear.

EGLN1 encodes proline hydroxylase 2 (PHD2), an isoform of HIF prolyl-hydroxylase. Homozygous knockout PHD2 mice are unviable and die at the embryonic stage due to severe placental defects (Takeda et al., 2006). Knockout mice with PHD2 disruption targeted to specific organs including the liver, heart, kidney and lung develop excessive vascular growth (Takeda et al., 2007). Adult mice deficient for PHD2 display excessive erythrocytosis (Takeda et al., 2008) and heterozygous PHD2 mice have an increased ventilatory sensitivity to hypoxia and carotid body hyperplasia (Bishop et al., 2013).

 Peroxisome Proliferator-Activated Nuclear Receptor A (PPARA)

PPARA encodes PPARα, a transcriptional regulator of fatty acid oxidation in liver, heart and muscle (Gilde and Van Bilsen, 2003). PPARA has tissue-specific expression and, under hypoxic conditions, is downregulated by HIFs (Narravula and Colgan, 2001). Positive selection across the PPARA gene has been reported in Tibetans (Simonson et al., 2010) and Sherpa (Horscroft et al., 2017), and the selected PPARA SNPs correlate with reduced hemoglobin levels (Simonson et al., 2010). Sherpa carriers of the positively selected PPARA alleles switch to more efficient fuels such as glucose and display decreased muscular fatty acid oxidation (Horscroft et al., 2017). Most of the PPARA SNPs reported to be under selection appear to be non-coding variants (Kinota et al., 2018). It is unclear if these variants directly affect transcriptional regulation or are linked with functional variants in other genes or nearby inter-genic regions.

 Conclusion

The Sherpa show remarkable performance in the hypoxic environment presented by high altitude. Comparative physiological studies have suggested numerous distinct, adaptive phenotypes in the Sherpa including advantageous levels of hemoglobin, oxygen saturation and birth weight, and the elevated reproductive success of Sherpa women. Genomic studies have identified robust signals of positive selection across genes including EPAS1, EGLN1 and PPARA. All three of these signals of genetic selection have been shown to correlate with advantageous levels of hemoglobin. However, Sherpa-specific signals of genetic selection have also been reported, suggesting that whilst some of the genetic basis for adaptation in the Sherpa is shared with Tibetans, there may be features unique to the Sherpa, which could in turn explain distinct Sherpa phenotypes. Collectively, this illustrates how the outstanding physiological performance of the Sherpa at altitude is, at least in part, a result of hypoxia driven genetic selection spanning the ∼35,000 years of seasonal migration on the Himalayan plateau. Further comparative physiological studies are required to refine existing, and identify additional adaptive phenotypes, in particular those that are specific to the Sherpa. By correlating these phenotypes with known and emerging signals of genetic selection, we can shed light on biological mechanisms of Sherpa hypoxic adaptation. Ultimately this work can inform on treatments of hypoxia-related illness including pulmonary, cardiac, neurological and renal disorders.

 Author Contributions

Both authors drafted, edited, and approved the final version of the manuscript.

 Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Funding. SB was supported by a Government of Ireland Postdoctoral Fellowship from the Irish Research Council (GOIPD/2018/408). This work was also supported by an Investigators Programme grant from Science Foundation Ireland (12/IP/1727).

 References Adams W. H. Shresta S. M. (1974). Hemoglobin levels, vitamin B12, and folate status in a Himalayan village. Am. J. Clin. Nutr. 27 217–219. 10.1093/ajcn/27.2.217 4812932 Adams W. H. Strang L. J. (1975). Hemoglobin levels in persons of Tibetan ancestry living at high altitude. Exp. Biol. Med. 149 1036–1039. 10.3181/00379727-149-38952 1166072 Ai H. Yang B. Li J. Xie X. Chen H. Ren J. (2014). Population history and genomic signatures for high-altitude adaptation in Tibetan pigs. BMC Genomics 15:834. 10.1186/1471-2164-15-834 25270331 Aldenderfer M. (2011). Peopling the Tibetan plateau: insights from archaeology. High Alt. Med. Biol. 12 141–147. 10.1089/ham.2010.1094 21718162 Allen P. Matheson G. Zhu G. Gheorgiu D. Dunlop R. Falconer T., et al. (1997). Simultaneous 31P MRS of the soleus and gastrocnemius in Sherpas during graded calf muscle exercise. Am. J. Physiol. Regul. Integr. Comp. Physiol. 273 R999–R1007 Arciero E. Kraaijenbrink T. Haber M. Mezzavilla M. Ayub Q. Wang W. (2018). Demographic history and genetic adaptation in the Himalayan region inferred from genome-wide SNP genotypes of 49 populations. Mol. Biol. Evol. 35 1916–1933. 10.1093/molbev/msy094 29796643 Ashmore T. Fernandez B. O. Evans C. E. Huang Y. Branco-Price C. Griffin J. L. (2014). Suppression of erythropoiesis by dietary nitrate. FASEB J. 29 1102–1112. 10.1096/fj.14-263004 25422368 Bailey D. M. Dehnert C. Luks A. M. Menold E. Castell C. Schendler G. (2010). High-altitude pulmonary hypertension is associated with a free radical-mediated reduction in pulmonary nitric oxide bioavailability. J. Physiol. 588 4837–4847. 10.1113/jphysiol.2010.194704 20876202 Barak Y. Sadovsky Y. Shalom-Barak T. (2008). PPAR signaling in placental development and function. PPAR Res. 2008:142082. 10.1155/2008/142082 18288278 Bastien G. Willems P. Schepens B. Heglund N. (2016). The mechanics of head-supported load carriage by Nepalese porters. J. Exp. Biol. 219 3626–3634. 10.1242/jeb.143875 27852764 Bastien G. J. Schepens B. Willems P. A. Heglund N. C. (2005a). Energetics of load carrying in Nepalese porters. Science 308 1755–1755. 10.1126/science.1111513 15961662 Bastien G. J. Willems P. A. Schepens B. Heglund N. C. (2005b). Effect of load and speed on the energetic cost of human walking. Eur. J. Appl. Physiol. 94 76–83. 10.1007/s00421-004-1286-z 15650888 Beall C. Reichsman A. (1984). Hemoglobin levels in a Himalayan high altitude population. Am. J. Phys. Anthropol. 63 301–306. 10.1002/ajpa.1330630306 6731601 Beall C. M. Cavalleri G. L. Deng L. Elston R. C. Gao Y. Knight J. (2010). Natural selection on EPAS1 (HIF2α) associated with low hemoglobin concentration in Tibetan highlanders. Proc. Natl. Acad. Sci. U.S.A. 107 11459–11464. 10.1073/pnas.1002443107 20534544 Beall C. M. Laskowski D. Erzurum S. C. (2012). Nitric oxide in adaptation to altitude. Free Radic. Biol. Med. 52 1123–1134. 10.1016/j.freeradbiomed.2011.12.028 22300645 Beall C. M. Song K. Elston R. C. Goldstein M. C. (2004). Higher offspring survival among Tibetan women with high oxygen saturation genotypes residing at 4,000 m. Proc. Natl. Acad. Sci. U.S.A. 101 14300–14304. 10.1073/pnas.0405949101 15353580 Beall C. M. Strohl K. P. Blangero J. Williams-Blangero S. Decker M. J. Brittenham G. M. (1997). Quantitative genetic analysis of arterial oxygen saturation in Tibetan highlanders. Hum. Biol. 69 597–604. 9299881 Bhandari S. Zhang X. Cui C. Liao S. Peng Y. Zhang H. (2015). Genetic evidence of a recent Tibetan ancestry to Sherpas in the Himalayan region. Sci. Rep. 5:16249. 10.1038/srep16249 26538459 Bhandari S. Zhang X. Cui C. Yangla Liu L. Ouzhuluobu Baimakangzhuo (2016). Sherpas share genetic variations with Tibetans for high-altitude adaptation. Mol. Genet. Genom. Med. 5 76–84. 10.1002/mgg3.264 28116332 Bigham A. Bauchet M. Pinto D. Mao X. Akey J. M. Mei R. (2010). Identifying signatures of natural selection in Tibetan and Andean populations using dense genome scan data. PLoS Genet 6:e1001116. 10.1371/journal.pgen.1001116 20838600 Bigham A. W. Mao X. Mei R. Brutsaert T. Wilson M. J. Julian C. G. (2009). Identifying positive selection candidate loci for high-altitude adaptation in Andean populations. Hum. Genomics 4 79–90. 20038496 Bishop T. Talbot N. P. Turner P. J. Nicholls L. G. Pascual A. Hodson E. J. (2013). Carotid body hyperplasia and enhanced ventilatory responses to hypoxia in mice with heterozygous deficiency of PHD2. J. Physiol. 591 3565–3577. 10.1113/jphysiol.2012.247254 23690557 Bogacka I. Kurzynska A. Bogacki M. Chojnowska K. (2015). Peroxisome proliferator-activated receptors in the regulation of female reproductive functions. Folia Histochem. Cytobiol. 53 189–200. 10.5603/fhc.a2015.0023 26339984 Boyer S. J. Blume F. D. (1984). Weight loss and changes in body composition at high altitude. J. Appl. Physiol. 57 1580–1585. 10.1152/jappl.1984.57.5.1580 6520055 Brooks G. Butterfield G. Wolfe R. Groves B. Mazzeo R. Sutton J. (1991). Increased dependence on blood glucose after acclimatization to 4,300 m. J. Appl. Physiol. 70 919–927. 10.1152/jappl.1991.70.2.919 2022585 Bruno R. M. Cogo A. Ghiadoni L. Duo E. Pomidori L. Sharma R. (2014). Cardiovascular function in healthy Himalayan high-altitude dwellers. Atherosclerosis 236 47–53. 10.1016/j.atherosclerosis.2014.06.017 25014034 Burton G. J. Fowden A. L. Thornburg K. L. (2016). Placental origins of chronic disease. Physiol. Rev. 96 1509–1565. 10.1152/physrev.00029.2015 27604528 Burtscher M. Gatterer H. Philadelphy M. Burtscher J. Likar R. (2018). Submaximal exercise testing at low altitude for prediction of exercise tolerance at high altitude. J. Travel Med. 25:tay011. 10.1093/jtm/tay011 29608739 Burtscher M. Philadelphy M. Gatterer H. Burtscher J. Faulhaber M. Nachbauer W. (2019). Physiological responses in humans acutely exposed to high altitude (3480?m): minute ventilation and oxygenation are predictive for the development of acute mountain sickness. High Alt. Med. Biol. 20 192–197. 10.1089/ham.2018.0143 30896981 Busch S. A. Davies H. Van Diepen S. Simpson L. L. Sobierajski F. Riske L. (2017). Chemoreflex mediated arrhythmia during apnea at 5,050 m in low-but not high-altitude natives. J. Appl. Physiol. 124 930–937. 10.1152/japplphysiol.00774.2017 29357505 Busch T. Bartsch P. Pappert D. Grunig E. Hildebrandt W. Elser H. (2001). Hypoxia decreases exhaled nitric oxide in mountaineers susceptible to high-altitude pulmonary edema. Am. J. Respir. Crit. Care Med. 163 368–373. 10.1164/ajrccm.163.2.2001134 11179108 Cho J. I. Basnyat B. Jeong C. Di Rienzo A. Childs G. Craig S. R. (2017). Ethnically Tibetan women in Nepal with low hemoglobin concentration have better reproductive outcomes. Evol. Med. Public Health 2017 82–96. 10.1093/emph/eox008 28567284 Cole A. M. Cox S. Jeong C. Petousi N. Aryal D. R. Droma Y. (2017). Genetic structure in the Sherpa and neighboring Nepalese populations. BMC Genomics 18:102. 10.1186/s12864-016-3469-5 28103797 Cumpstey A. F. Hennis P. J. Gilbert-Kawai E. T. Fernandez B. O. Poudevigne M. Cobb A. (2017). Effects of dietary nitrate on respiratory physiology at high altitude - Results from the Xtreme Alps study. Nitric Oxide 71 57–68. 10.1016/j.niox.2017.10.005 29042272 Cumpstey A. F. Minnion M. Fernandez B. O. Mikus-Lelinska M. Mitchell K. Martin D. S. (2019). Pushing arterial-venous plasma biomarkers to new heights: a model for personalised redox metabolomics? Redox Biol. 21:101113. 10.1016/j.redox.2019.101113 30738322 Davenport M. H. Steinback C. D. Borle K. J. Matenchuk B. A. Vanden Berg E. R. De Freitas E. M. (2018). Extreme pregnancy: maternal physical activity at Everest Base Camp. J. Appl. Physiol. 125 580–585. 10.1152/japplphysiol.00146.2018 29745793 Davies T. Gilbert-Kawai E. Wythe S. Meale P. Mythen M. Levett D. (2018). Sustained vasomotor control of skin microcirculation in Sherpas versus altitude-naive lowlanders: experimental evidence from Xtreme Everest 2. Exp. Physiol. 103 1494–1504. 10.1113/EP087236 30182473 Droma Y. Hanaoka M. Basnyat B. Arjyal A. Neupane P. Pandit A. (2006). Genetic contribution of the endothelial nitric oxide synthase gene to high altitude adaptation in sherpas. High Alt. Med. Biol. 7 209–220. 10.1089/ham.2006.7.209 16978133 Droma Y. Hanaoka M. Basnyat B. Arjyal A. Neupane P. Pandit A. (2008). Adaptation to high altitude in Sherpas: association with the insertion/deletion polymorphism in the Angiotensin-converting enzyme gene. Wilderness Environ. Med. 19 22–29. 10.1580/06-WEME-OR-073.1 18333655 Dunwoodie S. L. (2009). The role of hypoxia in development of the Mammalian embryo. Dev. Cell 17 755–773. 10.1016/j.devcel.2009.11.008 20059947 Edwards L. M. Murray A. J. Tyler D. J. Kemp G. J. Holloway C. J. Robbins P. A. (2010). The effect of high-altitude on human skeletal muscle energetics: 31 P-MRS results from the Caudwell Xtreme Everest expedition. PLoS One 5:e10681. 10.1371/journal.pone.0010681 20502713 Erzurum S. Ghosh S. Janocha A. Xu W. Bauer S. Bryan N. (2007). Higher blood flow and circulating NO products offset high-altitude hypoxia among Tibetans. Proc. Natl. Acad. Sci. U.S.A. 104 17593–17598. 10.1073/pnas.0707462104 17971439 Faoro V. Huez S. Vanderpool R. Groepenhoff H. De Bisschop C. Martinot J. B. (2014). Pulmonary circulation and gas exchange at exercise in Sherpas at high altitude. J. Appl. Physiol. 116 919–926. 10.1152/japplphysiol.00236.2013 23869067 Garrido E. Segura R. Capdevila A. Pujol J. Javierre C. Ventura J. L. (1996). Are Himalayan Sherpas better protected against brain damage associated with extreme altitude climbs? Clin. Sci. 90 81–85. 10.1042/cs0900081 8697710 Gelfi C. De Palma S. Ripamonti M. Eberini I. Wait R. Bajracharya A. (2004). New aspects of altitude adaptation in Tibetans: a proteomic approach. FASEB J. 18 612–614. 10.1096/fj.03-1077fje 14734630 Gilbert-Kawai E. Coppel J. Court J. Van Der Kaaij J. Vercueil A. Feelisch M. (2017). Sublingual microcirculatory blood flow and vessel density in Sherpas at high altitude. J. Appl. Physiol. 122 1011–1018. 10.1152/japplphysiol.00970.2016 28126908 Gilbert-Kawai E. Sheperdigian A. Adams T. Mitchell K. Feelisch M. Murray A. (2015). Design and conduct of Xtreme Everest 2: an observational cohort study of Sherpa and lowlander responses to graduated hypobaric hypoxia. F1000Res. 4:90. 10.12688/f1000research.6297.1 26064476 Gilbert-Kawai E. T. Milledge J. S. Grocott M. P. Martin D. S. (2014). King of the mountains: Tibetan and Sherpa physiological adaptations for life at high altitude. Physiology 29 388–402. 10.1152/physiol.00018.2014 25362633 Gilde A. Van Bilsen M. (2003). Peroxisome proliferator-activated receptors (PPARS): regulators of gene expression in heart and skeletal muscle. Acta Physiol. Scand. 178 425–434. 10.1046/j.1365-201x.2003.01161.x 12864748 Gill M. Pugh L. (1964). Basal metabolism and respiration in men living at 5,800 m (19,000 ft). J. Appl. Physiol. 19 949–954. 10.1152/jappl.1964.19.5.949 14207750 Gnecchi-Ruscone G. A. Abondio P. De Fanti S. Sarno S. Sherpa M. G. Sherpa P. T. (2018). Evidence of polygenic adaptation to high altitude from Tibetan and Sherpa genomes. Genome Biol. Evol. 10 2919–2930. 10.1093/gbe/evy233 30335146 Gnecchi-Ruscone G. A. Jeong C. De Fanti S. Sarno S. Trancucci M. Gentilini D. (2017). The genomic landscape of Nepalese Tibeto-Burmans reveals new insights into the recent peopling of Southern Himalayas. Sci. Rep. 7:15512. 10.1038/s41598-017-15862-z 29138459 Grocott M. P. Martin D. S. Levett D. Z. Mcmorrow R. Windsor J. Montgomery H. E. (2009). Arterial blood gases and oxygen content in climbers on Mount Everest. New Engl. J. Med. 360 140–149. 10.1056/NEJMoa0801581 19129527 Groves B. M. Droma T. Sutton J. R. Mccullough R. G. Mccullough R. E. Zhuang J. (1993). Minimal hypoxic pulmonary hypertension in normal Tibetans at 3,658 m. J. Appl. Physiol. 74 312–318. 10.1152/jappl.1993.74.1.312 8444708 Gruber M. Hu C.-J. Johnson R. S. Brown E. J. Keith B. Simon M. C. (2007). Acute postnatal ablation of Hif-2α results in anemia. Proc. Natl. Acad. Sci. U.S.A. 104 2301–2306. 10.1073/pnas.0608382104 17284606 Hackett P. H. Reeves J. T. Reeves C. D. Grover R. F. Rennie D. (1980). Control of breathing in Sherpas at low and high altitude. J. Appl. Physiol. 49 374–379. 10.1152/jappl.1980.49.3.374 7204157 Hanaoka M. Droma Y. Basnyat B. Ito M. Kobayashi N. Katsuyama Y. (2012). Genetic variants in EPAS1 contribute to adaptation to high-altitude hypoxia in Sherpas. PLoS One 7:e50566. 10.1371/journal.pone.0050566 23227185 Havryk A. P. Gilbert M. Burgess K. R. (2002). Spirometry values in Himalayan high altitude residents (Sherpas). Respir. Physiol. Neurobiol. 132 223–232. 10.1016/s1569-9048(02)00072-1 12161334 He Y. Qi X. Na O. Liu S. Li J. Zhang H. (2018). Blunted nitric oxide regulation in tibetans under high altitude hypoxia. Natl. Sci. Rev. 5 516–529. 10.1093/nsr/nwy037 Hilty M. P. Merz T. M. Hefti U. Ince C. Maggiorini M. Pichler Hefti J. (2019). Recruitment of non-perfused sublingual capillaries increases microcirculatory oxygen extraction capacity throughout ascent to 7126 m. J. Physiol. 597 2623–2638. 10.1113/JP277590 30843200 Hochachka P. W. Clark C. M. Holden J. E. Stanley C. Ugurbil K. Menon R. S. (1996a). 31P magnetic resonance spectroscopy of the Sherpa heart: a phosphocreatine/adenosine triphosphate signature of metabolic defense against hypobaric hypoxia. Proc. Natl. Acad. Sci. U.S.A. 93 1215–1220. 10.1073/pnas.93.3.1215 8577743 Hochachka P. W. Clark C. M. Monge C. Stanley C. Brown W. Stone C. (1996b). Sherpa brain glucose metabolism and defense adaptations against chronic hypoxia. J. Appl. Physiol. 81 1355–1361. 10.1152/jappl.1996.81.3.1355 8889774 Holden J. Stone C. Clark C. Brown W. Nickles R. Stanley C. (1995). Enhanced cardiac metabolism of plasma glucose in high-altitude natives: adaptation against chronic hypoxia. J. Appl. Physiol. 79 222–228. 10.1152/jappl.1995.79.1.222 7559223 Holloway C. J. Montgomery H. E. Murray A. J. Cochlin L. E. Codreanu I. Hopwood N. (2011). Cardiac response to hypobaric hypoxia: persistent changes in cardiac mass, function, and energy metabolism after a trek to Mt. Everest Base Camp. FASEB J. 25 792–796. 10.1096/fj.10-172999 20978235 Horscroft J. A. Kotwica A. O. Laner V. West J. A. Hennis P. J. Levett D. Z. (2017). Metabolic basis to Sherpa altitude adaptation. Proc. Natl. Acad. Sci. U.S.A. 114 6382–6387. 10.1073/pnas.1700527114 28533386 Hu H. Petousi N. Glusman G. Yu Y. Bohlender R. Tashi T. (2017). Evolutionary history of Tibetans inferred from whole-genome sequencing. PLoS Genetics 13:e1006675. 10.1371/journal.pgen.1006675 28448578 Huerta-Sánchez E. Jin X. Bianba Z. Peter B. M. Vinckenbosch N. Liang Y. (2014). Altitude adaptation in Tibetans caused by introgression of Denisovan-like DNA. Nature 512 194–197. 10.1038/nature13408 25043035 Janocha A. J. Comhair S. A. A. Basnyat B. Neupane M. Gebremedhin A. Khan A. (2017). Antioxidant defense and oxidative damage vary widely among high-altitude residents. Am. J. Hum. Biol. 29:e23039. 10.1002/ajhb.23039 28726295 Jansen G. F. Krins A. Basnyat B. Bosch A. Odoom J. A. (2000). Cerebral autoregulation in subjects adapted and not adapted to high altitude. Stroke 31 2314–2318. 10.1161/01.str.31.10.2314 11022056 Jansen G. F. Krins A. Basnyat B. Odoom J. A. Ince C. (2007). Role of the altitude level on cerebral autoregulation in residents at high altitude. J. Appl. Physiol. 103 518–523. 10.1152/japplphysiol.01429.2006 17463295 Jeansson M. Gawlik A. Anderson G. Li C. Kerjaschki D. Henkelman M. (2011). Angiopoietin-1 is essential in mouse vasculature during development and in response to injury. J. Clin. Invest. 121 2278–2289. 10.1172/JCI46322 21606590 Jeong C. Alkorta-Aranburu G. Basnyat B. Neupane M. Witonsky D. B. Pritchard J. K. (2014). Admixture facilitates genetic adaptations to high altitude in Tibet. Nat. Commun. 5:3281. 10.1038/ncomms4281 24513612 Jeong C. Ozga A. T. Witonsky D. B. Malmström H. Edlund H. Hofman C. A. (2016). Long-term genetic stability and a high-altitude East Asian origin for the peoples of the high valleys of the Himalayan arc. Proc. Natl. Acad. Sci. 113 7485–7490. 10.1073/pnas.1520844113 27325755 Jeong C. Witonsky D. B. Basnyat B. Neupane M. Beall C. M. Childs G. (2018). Detecting past and ongoing natural selection among ethnically Tibetan women at high altitude in Nepal. PLoS Genetics 14:e1007650. 10.1371/journal.pgen.1007650 30188897 Jones A. Montgomery H. E. Woods D. R. (2002). Human performance: a role for the ACE genotype? Exerc. Sport Sci. Rev. 30 184–190. 10.1097/00003677-200210000-00008 12398116 Julian C. G. Wilson M. J. Moore L. G. (2009). Evolutionary adaptation to high altitude: a view from in utero. Am. J. Hum. Biol. 21 614–622. 10.1002/ajhb.20900 19367578 Kang L. Zheng H.-X. Chen F. Yan S. Liu K. Qin Z. (2013). mtDNA lineage expansions in Sherpa population suggest adaptive evolution in Tibetan highlands. Mol. Biol. Evol. 30 2579–2587. 10.1093/molbev/mst147 24002810 Kayser B. Hoppeler H. Claassen H. Cerretelli P. (1991). Muscle structure and performance capacity of Himalayan Sherpas. J. Appl. Physiol. 70 1938–1942. 10.1152/jappl.1991.70.5.1938 1864773 Kinota F. Droma Y. Kobayashi N. Horiuchi T. Kitaguchi Y. Yasuo M. (2018). The contribution of genetic variants of the peroxisome proliferator-activated receptor-alpha gene to high-altitude hypoxia adaptation in Sherpa highlanders. High Alt. Med. Biol. [Epub ahead of print]. 30475063 Lahiri S. Milledge J. (1965). Sherpa physiology. Nature 207 610–612. 10.1038/207610a0 5883635 Lahiri S. Milledge J. (1967). Acid-base in Sherpa altitude residents and lowlanders at 4880 m. Respir. Physiol. 2 323–334. 10.1016/0034-5687(67)90037-0 Lahiri S. Milledge J. S. Chattopadhyay H. P. Bhattacharyya A. K. Sinha A. K. (1967). Respiration and heart rate of Sherpa highlanders during exercise. J. Appl. Physiol. 23 545–554. 10.1152/jappl.1967.23.4.545 6053681 Leacy J. K. Zouboules S. M. Mann C. R. Peltonen J. D. B. Saran G. Nysten C. E. (2018). Neurovascular coupling remains intact during incremental ascent to high altitude (4240 m) in acclimatized healthy volunteers. Front. Physiol. 9:1691. 10.3389/fphys.2018.01691 30546319 Leon-Velarde F. Maggiorini M. Reeves J. T. Aldashev A. Asmus I. Bernardi L. (2005). Consensus statement on chronic and subacute high altitude diseases. High Alt. Med. Biol. 6 147–157. 10.1089/ham.2005.6.147 16060849 Levett D. Z. Vigano A. Capitanio D. Vasso M. De Palma S. Moriggi M. (2015). Changes in muscle proteomics in the course of the caudwell research expedition to Mt. Everest. Proteomics 15 160–171. 10.1002/pmic.201400306 25370915 Lewis N. Bailey D. M. Dumanoir G. R. Messinger L. Lucas S. J. Cotter J. D. (2014). Conduit artery structure and function in lowlanders and native highlanders: relationships with oxidative stress and role of sympathoexcitation. J. Physiol. 592 1009–1024. 10.1113/jphysiol.2013.268615 24324004 Li K. Gesang L. Dan Z. Gusang L. (2016). Genome-wide transcriptional analysis reveals the protection against hypoxia-induced oxidative injury in the intestine of Tibetans via the inhibition of GRB2/EGFR/PTPN11 pathways. Oxid. Med. Cell. Longev. 2016:6967396. 10.1155/2016/6967396 27594973 Lorenzo F. R. (2010). “Novel PHD2 mutation associated with Tibetan genetic adaptation to high altitude hypoxia,” in Proceedings of the ASH 52nd Annual Meeting, (Orlando, FL: ASH). Lorenzo F. R. Huff C. Myllymäki M. Olenchock B. Swierczek S. Tashi T. (2014). A genetic mechanism for Tibetan high-altitude adaptation. Nat. Genet. 46 951–956. 10.1038/ng.3067 25129147 Lou H. Lu Y. Lu D. Fu R. Wang X. Feng Q. (2015). A 3.4-kb Copy-Number Deletion near EPAS1 is significantly enriched in high-altitude Tibetans but absent from the denisovan sequence. Am. J. Hum. Genet. 97 54–66. 10.1016/j.ajhg.2015.05.005 26073780 Lu D. Lou H. Yuan K. Wang X. Wang Y. Zhang C. (2016). Ancestral origins and genetic history of Tibetan highlanders. Am. J. Hum. Genet. 99 580–594. 10.1016/j.ajhg.2016.07.002 27569548 Luks A. M. Hackett P. H. (2014). “High altitude and common medical conditions,” in Human Adaptation to Hypoxia, eds Swenson E. R. Bartsch P. (New York, NY: Springer), 449–477. 10.1007/978-1-4614-8772-2_23 Luks A. M. Levett D. Martin D. S. Goss C. H. Mitchell K. Fernandez B. O. (2017). Changes in acute pulmonary vascular responsiveness to hypoxia during a progressive ascent to high altitude (5300 m). Exp. Physiol. 102 711–724. 10.1113/EP086083 28390080 Lundby C. Calbet J. Van Hall G. Saltin B. Sander M. (2018). Sustained sympathetic activity in altitude acclimatizing lowlanders and high-altitude natives. Scand. J. Med. Sci. Sports 28 854–861. 10.1111/sms.12976 28948697 Marconi C. Marzorati M. Grassi B. Basnyat B. Colombini A. Kayser B. (2004). Second generation Tibetan lowlanders acclimatize to high altitude more quickly than Caucasians. J. Physiol. Lond. 556 661–671. 10.1113/jphysiol.2003.059188 14766936 Martin D. S. Gilbert-Kawai E. Levett D. Z. Mitchell K. Kumar Bc. R. Mythen M. G. (2013). Xtreme Everest 2: unlocking the secrets of the Sherpa phenotype? Extreme Physiol. Med. 2 30–30. 10.1186/2046-7648-2-30 24229457 Martin D. S. Ince C. Goedhart P. Levett D. Z. Grocott M. P. Caudwell Xtreme Everest Research G. (2009). Abnormal blood flow in the sublingual microcirculation at high altitude. Eur. J. Appl. Physiol. 106 473–478. 10.1007/s00421-009-1023-8 19333616 Milledge J. S. (2002). The “Silver Hut” expedition—A commentary 40 years later. Wilderness Environ. Med. 13 55–56.10.1580/1080-6032(2002)013 Montgomery H. E. Marshall R. Hemingway H. Myerson S. Clarkson P. Dollery C. (1998). Human gene for physical performance. Nature 393 221–222. Moore L. G. (2003). Fetal growth restriction and maternal oxygen transport during high altitude pregnancy. High Alt. Med. Biol. 4 141–156. 10.1089/152702903322022767 12855048 Moore L. G. (2017). Measuring high-altitude adaptation. J. Appl. Physiol. 123 1371–1385. 10.1152/japplphysiol.00321.2017 28860167 Moore L. G. Charles S. M. Julian C. G. (2011). Humans at high altitude: hypoxia and fetal growth. Respir. Physiol. Neurobiol. 178 181–190. 10.1016/j.resp.2011.04.017 21536153 Moore L. G. Young D. Mccullough R. E. Droma T. Zamudio S. (2001). Tibetan protection from intrauterine growth restriction (IUGR) and reproductive loss at high altitude. Am. J. Hum. Biol. 13 635–644. 10.1002/ajhb.1102.abs 11505472 Morpurgo G. Arese P. Bosia A. Pescarmona G. Luzzana M. Modiano G. (1976). Sherpas living permanently at high altitutde: a new pattern of adaptation. Proc. Natl. Acad. Sci. U.S.A. 73 747–751. 10.1073/pnas.73.3.747 1062785 Murray A. J. (2009). Metabolic adaptation of skeletal muscle to high altitude hypoxia: how new technologies could resolve the controversies. Genome Med. 1 117–117. 10.1186/gm117 20090895 Narravula S. Colgan S. P. (2001). Hypoxia-inducible factor 1-mediated inhibition of peroxisome proliferator-activated receptor α expression during hypoxia. J. Immunol. 166 7543–7548. 10.4049/jimmunol.166.12.7543 11390509 Neubauer S. Horn M. Cramer M. Harre K. Newell J. B. Peters W. (1997). Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 96 2190–2196. 10.1161/01.cir.96.7.2190 9337189 Oppitz M. (1974). Myths and facts: reconsidering some data concerning the clan history of the Sherpas. Kailash 2 121–131. Pagani L. Ayub Q. Macarthur D. G. Xue Y. Baillie J. K. Chen Y. (2012). High altitude adaptation in Daghestani populations from the Caucasus. Hum. Genet. 131 423–433. 10.1007/s00439-011-1084-8 21904933 Patitucci M. Lugrin D. (2009). Angiogenic/lymphangiogenic factors and adaptation to extreme altitudes during an expedition to Mount Everest. Acta Physiol. 196 259–265. 10.1111/j.1748-1716.2008.01915.x 18983460 Peng Y. Cui C. He Y. Zhang H. Yang D. Zhang Q. (2017). Down-regulation of EPAS1 transcription and genetic adaptation of Tibetans to high-altitude hypoxia. Mol. Biol. Evol. 34 818–830. 10.1093/molbev/msw280 28096303 Peng Y. Yang Z. Zhang H. Cui C. Qi X. Luo X. (2011). Genetic variations in Tibetan populations and high-altitude adaptation at the Himalayas. Mol. Biol. Evol. 28 1075–1081. 10.1093/molbev/msq290 21030426 Percy M. J. Furlow P. W. Lucas G. S. Li X. Lappin T. R. Mcmullin M. F. (2008). A gain-of-function mutation in the HIF2A gene in familial erythrocytosis. New Engl. J. Med. 358 162–168. Pringle K. Kind K. Sferruzzi-Perri A. Thompson J. Roberts C. (2009). Beyond oxygen: complex regulation and activity of hypoxia inducible factors in pregnancy. Hum. Reprod. update 16 415–431. 10.1093/humupd/dmp046 19926662 Pugh L. Gill M. Lahiri S. Milledge J. Ward M. West J. (1964). Muscular exercise at great altitudes. J. Appl. Physiol. 19 431–440. 10.1152/jappl.1964.19.3.431 14173539 Pugh L. G. C. E. (1962). Physiological and medical aspects of the Himalayan scientific and mountaineering expedition. BMJ 2 621–627. 10.1136/bmj.2.5305.621 14489161 Qi X. Cui C. Peng Y. Zhang X. Yang Z. Zhong H. (2013). Genetic evidence of Paleolithic colonization and Neolithic expansion of modern humans on the Tibetan Plateau. Mol. Biol. Evol. 30 1761–1778. 10.1093/molbev/mst093 23682168 Ruggiero L. Hoiland R. L. Hansen A. B. Ainslie P. N. Mcneil C. J. (2018). UBC-Nepal expedition: peripheral fatigue recovers faster in Sherpa than lowlanders at high altitude. J. Physiol. 596 5365–5377. 10.1113/JP276599 30239002 Ruggiero L. Mcneil C. J. (2018). Supraspinal fatigue and neural-evoked responses in Lowlanders and Sherpa at 5050 m. Med. Sci. Sports Exerc. 51 183–192. 10.1249/MSS.0000000000001748 30095744 Samaja M. Mariani C. Prestini A. Cerretelli P. (1997). Acid-base balance and O2 transport at high altitude. Acta Physiol. Scand. 159 249–256. 10.1046/j.1365-201x.1997.574342000.x 9079156 Samaja M. Veicsteinas A. Cerretelli P. (1979). Oxygen affinity of blood in altitude Sherpas. J. Appl. Physiol. 47 337–341. 10.1152/jappl.1979.47.2.337 468690 Santolaya R. B. Lahiri S. Alfaro R. T. Schoene R. B. (1989). Respiratory adaptation in the highest inhabitants and highest Sherpa mountaineers. Respir. Physiol. 77 253–262. 10.1016/0034-5687(89)90011-x 2506621 Scheinfeldt L. B. Soi S. Thompson S. Ranciaro A. Woldemeskel D. Beggs W. (2012). Genetic adaptation to high altitude in the Ethiopian highlands. Genome Biol. 13:R1. 10.1186/gb-2012-13-1-r1 22264333 Scheinfeldt L. B. Tishkoff S. A. (2013). Recent human adaptation: genomic approaches, interpretation and insights. Nat. Rev. Genet. 14 692–702. 10.1038/nrg3604 24052086 Schneider A. Greene R. E. Keyl C. Bandinelli G. Passino C. Spadacini G. (2001). Peripheral arterial vascular function at altitude: sea-level natives versus Himalayan high-altitude natives. J. Hypertens. 19 213–222. 10.1097/00004872-200102000-00007 11212963 Schoene R. Lahiri S. Hackett P. Peters R. Milledge J. Pizzo C. (1984). Relationship of hypoxic ventilatory response to exercise performance on Mount Everest. J. Appl. Physiol. 56 1478–1483. 10.1152/jappl.1984.56.6.1478 6735806 Simonson T. S. (2015). Altitude adaptation: a glimpse through various lenses. High Alt. Med. Biol. 16 125–137. 10.1089/ham.2015.0033 26070057 Simonson T. S. Wei G. Wagner H. E. Wuren T. Qin G. Yan M. (2015). Low haemoglobin concentration in Tibetan males is associated with greater high-altitude exercise capacity. J. Physiol. 593 3207–3218. 10.1113/JP270518 25988759 Simonson T. S. Yang Y. Huff C. D. Yun H. Qin G. Witherspoon D. J. (2010). Genetic evidence for high-altitude adaptation in Tibet. Science 329 72–75. 10.1126/science.1189406 20466884 Simpson L. L. Busch S. A. Oliver S. J. Ainslie P. N. Stembridge M. Steinback C. D. (2019). Baroreflex control of sympathetic vasomotor activity and resting arterial pressure at high altitude: insight from Lowlanders and Sherpa. J. Physiol. 597 2379–2390. 10.1113/JP277663 30893472 Smith C. (1997). The effect of maternal nutritional variables on birthweight outcomes of infants born to Sherpa women at low and high altitudes in Nepal. Am. J. Hum. Biol. 9 751–763. 10.1002/(SICI)1520-630019979:6 28561390 Song D. Li L.-S. Arsenault P. R. Tan Q. Bigham A. W. Heaton-Johnson K. J. (2014). Defective Tibetan PHD2 binding to p23 links high altitude adaptation to altered oxygen sensing. J. Biol. Chem. 289 14656–14665. 10.1074/jbc.M113.541227 24711448 Stembridge M. Ainslie P. N. Boulet L. M. Anholm J. Subedi P. Tymko M. M. (2019). The independent effects of hypovolaemia and pulmonary vasoconstriction on ventricular function and exercise capacity during acclimatisation to 3800 m. J. Physiol. 597 1059–1072. 10.1113/JP275278 29808473 Stembridge M. Ainslie P. N. Hughes M. G. Stöhr E. J. Cotter J. D. Nio A. Q. (2014). Ventricular structure, function, and mechanics at high altitude: chronic remodeling in Sherpa vs. short-term lowlander adaptation. J. Appl. Physiol. 117 334–343. 10.1152/japplphysiol.00233.2014 24876358 Stembridge M. Ainslie P. N. Shave R. (2015). Short-term adaptation and chronic cardiac remodelling to high altitude in lowlander natives and Himalayan Sherpa. Exp. Physiol. 100 1242–1246. 10.1113/expphysiol.2014.082503 26575341 Sutton J. R. Reeves J. T. Wagner P. D. Groves B. M. Cymerman A. Malconian M. K. (1988). Operation Everest II: oxygen transport during exercise at extreme simulated altitude. J. Appl. Physiol. 64 1309–1321. 10.1152/jappl.1988.64.4.1309 3132445 Suzuki K. Kizaki T. Hitomi Y. Nukita M. Kimoto K. Miyazawa N. (2003). Genetic variation in hypoxia-inducible factor 1α and its possible association with high altitude adaptation in Sherpas. Med. Hypotheses 61 385–389. 10.1016/s0306-9877(03)00178-6 Takeda K. Aguila H. L. Parikh N. S. Li X. Lamothe K. Duan L.-J. (2008). Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins. Blood 111 3229–3235. 10.1182/blood-2007-09-114561 18056838 Takeda K. Cowan A. Fong G.-H. (2007). Essential role for prolyl hydroxylase domain protein 2 in oxygen homeostasis of the adult vascular system. Circulation 116 774–781. 10.1161/circulationaha.107.701516 17646578 Takeda K. Ho V. C. Takeda H. Duan L.-J. Nagy A. Fong G.-H. (2006). Placental but not heart defects are associated with elevated hypoxia-inducible factor α levels in mice lacking prolyl hydroxylase domain protein 2. Mol. Cell. Biol. 26 8336–8346. 10.1128/mcb.00425-06 16966370 Tan Q. Kerestes H. Percy M. J. Pietrofesa R. Chen L. Khurana T. S. (2013). Erythrocytosis and pulmonary hypertension in a mouse model of human HIF2A gain-of-function mutation. J. Biol. Chem. 289 14656–14665. 10.1074/jbc.M112.444059 23640890 Tannheimer M. Van Der Spek R. Brenner F. Lechner R. Steinacker J. M. Treff G. (2017). Oxygen saturation increases over the course of the night in mountaineers at high altitude (3050-6354 m). J. Travel Med. 24:tax041. 10.1093/jtm/tax041 28931132 Tremblay J. C. Hoiland R. L. Carter H. H. Howe C. A. Stembridge M. Willie C. K. (2018). UBC-nepal expedition: upper and lower limb conduit artery shear stress and flow-mediated dilation on ascent to 5050 m in Lowlanders and Sherpa. Am. J. Physiol. Heart Circ. Physiol. 315 H1532–H1543. 10.1152/ajpheart.00345.2018 30168724 Tremblay J. C. Thom S. R. Yang M. Ainslie P. N. (2017). Oscillatory shear stress, flow-mediated dilatation, and circulating microparticles at sea level and high altitude. Atherosclerosis 256 115–122. 10.1016/j.atherosclerosis.2016.12.004 28010936 Tymko M. M. Tremblay J. C. Hansen A. B. Howe C. A. Willie C. K. Stembridge M. (2017a). The effect of alpha1 -adrenergic blockade on post-exercise brachial artery flow-mediated dilatation at sea level and high altitude. J. Physiol. 595 1671–1686. 10.1113/JP273183 28032333 Tymko M. M. Tremblay J. C. Steinback C. D. Moore J. P. Hansen A. B. Patrician A. (2017b). UBC-Nepal Expedition: acute alterations in sympathetic nervous activity do not influence brachial artery endothelial function at sea level and high altitude. J. Appl. Physiol. 123 1386–1396. 10.1152/japplphysiol.00583.2017 28860174 Wang B. Zhang Y.-B. Zhang F. Lin H. Wang X. Wan N. (2011). On the origin of Tibetans and their genetic basis in adapting high-altitude environments. PLoS One 6:e17002. 10.1371/journal.pone.0017002 21386899 Weitz C. A. Garruto R. M. (2007). A comparative analysis of arterial oxygen saturation among Tibetans and Han born and raised at high altitude. High Alt. Med. Biol. 8 13–26. 10.1089/ham.2006.1043 17394413 Willie C. K. Stembridge M. Hoiland R. L. Tymko M. M. Tremblay J. C. Patrician A. (2018). UBC-nepal expedition: an experimental overview of the 2016 University of British Columbia scientific expedition to Nepal Himalaya. PLoS One 13:e0204660. 10.1371/journal.pone.0204660 30379823 Wilson M. H. Edsell M. E. Davagnanam I. Hirani S. P. Martin D. S. Levett D. Z. (2011). Cerebral artery dilatation maintains cerebral oxygenation at extreme altitude and in acute hypoxia—an ultrasound and MRI study. J. Cereb. Blood Flow Metab. 31 2019–2029. 10.1038/jcbfm.2011.81 21654697 Winslow R. M. Chapman K. W. Gibson C. C. Samaja M. Monge C. C. Goldwasser E. (1989). Different hematologic responses to hypoxia in Sherpas and Quechua Indians. J. Appl. Physiol. 66 1561–1569. 10.1152/jappl.1989.66.4.1561 2732148 Wu T. (1990). Changes in cardiac function at rest and during exercise in mountaineers at an extreme altitude. Zhonghua Yi Xue Za Zhi 70 72–76. 2161270 Wu T. Kayser B. (2006). High altitude adaptation in Tibetans. High Alt. Med. Biol. 7 193–208. 10.1089/ham.2006.7.193 16978132 Wu T. Liu F. Cui C. Qi X. Su B. (2013). A genetic adaptive pattern-low hemoglobin concentration in the Himalayan highlanders. Chin. J. Appl. Physiol. 29 481–493. 24654529 Xiang K. Ouzhuluobu, Peng Y. Yang Z. Zhang X. Cui C. (2013). Identification of a Tibetan-specific mutation in the hypoxic gene EGLN1 and its contribution to high-altitude adaptation. Mol. Biol. Evol. 30 1889–1898. 10.1093/molbev/mst090 23666208 Xing J. Wuren T. Simonson T. S. Watkins W. S. Witherspoon D. J. Wu W. (2013). Genomic analysis of natural selection and phenotypic variation in high-altitude Mongolians. PLoS Genetics 9:e1003634. 10.1371/journal.pgen.1003634 23874230 Xu S. Li S. Yang Y. Tan J. Lou H. Jin W. (2011). A genome-wide search for signals of high-altitude adaptation in Tibetans. Mol. Biol. Evol. 28 1003–1011. 10.1093/molbev/msq277 20961960 Yi X. Liang Y. Huerta-Sanchez E. Jin X. Cuo Z. X. P. Pool J. E. (2010). Sequencing of 50 human exomes reveals adaptation to high altitude. Science 329 75–78. 10.1126/science.1190371 20595611 Zhang C. Lu Y. Feng Q. Wang X. Lou H. Liu J. (2017). Differentiated demographic histories and local adaptations between Sherpas and Tibetans. Genome Biol. 18 115. 10.1186/s13059-017-1242-y 28619099 Zhang X. Ha B. Wang S. Chen Z. Ge J. Long H. (2018). The earliest human occupation of the high-altitude Tibetan Plateau 40 thousand to 30 thousand years ago. Science 362 1049–1051. 10.1126/science.aat8824 30498126 Zhuang J. Droma T. Sun S. Janes C. Mccullough R. E. Mccullough R. G. (1993). Hypoxic ventilatory responsiveness in Tibetan compared with Han residents of 3,658 m. J. Appl. Physiol. 74 303–311. 10.1152/jappl.1993.74.1.303 8444707